A contract manufacturing organization (CMO), sometimes called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
Based on the Contract Research Organization (CRO) and CDMO for Pharmaceutical market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market covered in Chapter 5:
EPS INTERNATIONAL
Pharmaceutical Product Development Inc
GenScript Biotech Corporation
Medpace Holdings, Inc
Charles River Laboratories, Inc
IQVIA HOLDINGS INC
Syneos Health Inc
WuXi AppTec
Laboratory Corporation of America Holdings (LABCORP)
PAREXEL International Corporation
Eurofins Scientific
SGS SA
Envigo
ICON PLC
PRA HEALTH SCIENCES, INC
EVOTEC AG
In Chapter 6, on the basis of types, the Contract Research Organization (CRO) and CDMO for Pharmaceutical market from 2015 to 2025 is primarily split into:
Protein Production & Purification Service
Antibody Production & Development Service
Transient Transfection CRO Service
Molecular Biology Service
Others
In Chapter 7, on the basis of applications, the Contract Research Organization (CRO) and CDMO for Pharmaceutical market from 2015 to 2025 covers:
Pharmaceutical and Biopharmaceutical Companies
Academic Institutes
Research Institutes
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Summary:
Get latest Market Research Reports on Contract Research Organization (CRO) and CDMO for Pharmaceutical. Industry analysis & Market Report on Contract Research Organization (CRO) and CDMO for Pharmaceutical is a syndicated market report, published as Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Contract Research Organization (CRO) and CDMO for Pharmaceutical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.